Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.970
+0.150 (3.11%)
Nov 21, 2024, 2:14 PM EST - Market open
MRVI Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for MRVI stock have an average target of 10.33, with a low estimate of 7.00 and a high estimate of 15. The average target predicts an increase of 107.85% from the current stock price of 4.97.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MRVI stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 9 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $13 | Buy | Maintains | $17 → $13 | +161.57% | Nov 8, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2024 |
| Baird | Baird | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +81.09% | Nov 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +40.85% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
275.50M
from 288.95M
Decreased by -4.65%
Revenue Next Year
295.06M
from 275.50M
Increased by 7.10%
EPS This Year
-0.05
from -0.90
EPS Next Year
0.02
from -0.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 294.0M | 318.1M | 366.6M | ||
| Avg | 275.5M | 295.1M | 339.0M | ||
| Low | 250.4M | 254.8M | 274.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.7% | 15.4% | 24.2% | ||
| Avg | -4.7% | 7.1% | 14.9% | ||
| Low | -13.3% | -7.5% | -7.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.02 | 0.06 | 0.16 | ||
| Avg | -0.05 | 0.02 | 0.09 | ||
| Low | -0.10 | -0.03 | 0.03 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 742.0% | ||
| Avg | - | - | 394.1% | ||
| Low | - | - | 56.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.